Please assess the completion status of the following clinical trial:

Trial Title: Effects on Small Airways of Two Long-term Extrafine Treatments in Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Moderate persistent bronchial asthma according to GINA guidelines~Exclusion Criteria:~Associated respiratory diseases Smoking history Oral corticosteroid in the previous six months Pregnant women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SF (Type: ACTIVE_COMPARATOR): Extrafine Fluticasone/Salmeterol
- FB (Type: ACTIVE_COMPARATOR): Extrafine Formoterol and beclometasone HFA

Based on this trial design, predict the completion outcome and termination type (if applicable).